Research Topics
| D SviridovSummaryAffiliation: Baker Heart Research Institute Country: Australia Publications
| Collaborators
|
Detail Information
Publications
Efflux of cellular cholesterol and phospholipid to apolipoprotein A-I mutantsD Sviridov
Baker Medical Research Institute, Commercial Road, Prahran, Victoria 3181, Australia
J Biol Chem 271:33277-83. 1996..A second lipid-binding region is exposed when the carboxyl-terminal half of apoA-I is absent...
Low-density lipoprotein receptor and apolipoprotein A-I and B expression in human enterocytesDmitri Sviridov
Molecular Disease Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA
Digestion 67:67-70. 2003..Immunoprecipitation of [(35)S]methionine pulse-labeled intracellular proteins from these cell types demonstrated that human enterocytes synthesize more apoA-I and apoB, while HepG2 cells synthesize a slightly higher amount of LDL-R...
Statins and metabolism of high density lipoproteinDmitri Sviridov
Baker Heart Research Institute, Commercial Rd, Central, Melbourne, Vic, 8008, Australia
Cardiovasc Hematol Agents Med Chem 5:215-21. 2007..In this review we analyze what is currently known about effect of statins on HDL metabolism and on reverse cholesterol transport in particular...
Single session exercise stimulates formation of pre beta 1-HDL in leg muscleDmitri Sviridov
Wynn Domain, Baker Medical Research Institute, PO Box 6492 St Kilda Rd Central, Melbourne, Victoria, 8008, Australia
J Lipid Res 44:522-6. 2003..In the combined population, formation of pre beta 1-HDL at rest was 9.9 +/- 5.2 mg/min and exercise enhanced pre beta 1-HDL formation 6.6-fold in both groups...
Delineation of the role of pre-beta 1-HDL in cholesterol efflux using isolated pre-beta 1-HDLDmitri Sviridov
Baker Medical Research Institute, Melbourne, Victoria, Australia
Arterioscler Thromb Vasc Biol 22:1482-8. 2002....
Antiatherogenic functionality of high density lipoprotein: how much versus how goodDmitri Sviridov
Baker Heart Research Institute, St Kilda Road Central, Melbourne, Victoria 8008, Australia
J Atheroscler Thromb 15:52-62. 2008..A single common denominator reflecting the multiple HDL functions is yet to be found and may not exist leaving direct measurements of each HDL function as the way to assess atheroprotective capacity of HDL...
Dynamics of reverse cholesterol transport: protection against atherosclerosisDmitri Sviridov
Baker Medical Research Institute, PO Box 6492, St Kilda Rd Central, Melbourne, VIC 8008, Australia
Atherosclerosis 161:245-54. 2002..The particular role of pre-beta(1)-HDL is reviewed drawing attention to the relationship between its concentration and the flux of cholesterol through the RCT system...
Apolipoprotein A-I stimulates the transport of intracellular cholesterol to cell-surface cholesterol-rich domains (caveolae)D Sviridov
Baker Medical Research Institute, P O Box 6492, Melbourne, VIC 8008, Australia
Biochem J 358:79-86. 2001..2-fold. We conclude that apoA-I induces the transport of intracellular cholesterol to cell-surface caveolae, possibly in part through the stimulation of caveolin expression...
Identification of a sequence of apolipoprotein A-I associated with the activation of Lecithin:Cholesterol acyltransferaseD Sviridov
Baker Medical Research Institute, Melbourne 8008 and the Department of Biochemistry, University of Melbourne, Parkville 3052, Victoria, Australia
J Biol Chem 275:19707-12. 2000....
Intracellular cholesterol traffickingD Sviridov
Baker Medical Research Institute, Melbourne, Australia
Histol Histopathol 14:305-19. 1999..In this review we describe the intracellular machinery involved in the intracellular transfer of cholesterol and give an overview of both the general and specialized pathways of intracellular cholesterol trafficking known to date...
Elevated HDL cholesterol is functionally ineffective in cardiac transplant recipients: evidence for impaired reverse cholesterol transportDmitri Sviridov
Baker Heart Research Institute, Melbourne, Victoria, Australia
Transplantation 81:361-6. 2006..Cardiac transplant recipients frequently have high plasma HDL levels but it is unclear whether these promote a cardioprotective profile...
Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic propertiesA Hoang
Baker Heart Research Institute, St Kilda Road Central, Melbourne, Victoria 8008, Australia
Diabetologia 50:1770-9. 2007..However, the precise mechanisms remain to be established. In the present study, we examined whether AGE modification of apolipoprotein A-I (apoA-I) affects its functionality, thus altering its cardioprotective profile...
Enhancing apolipoprotein A-I-dependent cholesterol efflux elevates cholesterol export from macrophages in vivoNigora Mukhamedova
BakerIDI Heart and Diabetes Institute, Melbourne, Victoria, Australia
J Lipid Res 49:2312-22. 2008..We conclude that pathways of cholesterol efflux using apoA-I as an acceptor make a predominant contribution to cholesterol export from macrophages in vivo...
The role of different regions of ATP-binding cassette transporter A1 in cholesterol effluxNigora Mukhamedova
Baker Heart Research Institute, P O Box 6492, St Kilda Road Central, Melbourne, Victoria, 8008 Australia
Biochemistry 46:9388-98. 2007..We conclude that a site on the first extracellular loop is required for cholesterol efflux, whereas a site on the fourth extracellular loop may be responsible for ABCA1 stability...
5A apolipoprotein mimetic peptide promotes cholesterol efflux and reduces atherosclerosis in miceMarcelo J A Amar
Lipoprotein Metabolism Section, Pulmonary and Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
J Pharmacol Exp Ther 334:634-41. 2010..In summary, 5A promotes cholesterol efflux both in vitro and in vivo and reduces atherosclerosis in apoE-KO mice, indicating that it may be a useful alternative to apoA-I for HDL therapy...
HIV infection and high density lipoprotein metabolismHonor Rose
Baker Heart Research Institute, Melbourne, Australia
Atherosclerosis 199:79-86. 2008..Taken together these results suggest that HIV infection is associated with modified HDL metabolism re-directing cholesterol to the apoB-containing lipoproteins and likely reducing the functionality of reverse cholesterol transport...
High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitusBrian G Drew
Baker IDI Heart and Diabetes Institute, Melbourne, Australia
Circulation 119:2103-11. 2009..We hypothesized that HDL modulates glucose metabolism via elevation of plasma insulin and through activation of the key metabolic regulatory enzyme, AMP-activated protein kinase, in skeletal muscle...
Cholesterol efflux from macrophages is influenced differentially by plasmas from overweight insulin-sensitive and -resistant subjectsP Nestel
Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia
Int J Obes (Lond) 36:407-13. 2012..We investigated whether cholesterol efflux from macrophages incubated with plasmas from overweight/obese subjects with metabolic syndrome was influenced by the presence of insulin resistance...
Effectivity of expression of mature forms of mutant human apolipoprotein A-ID Sviridov
Baker Medical Research Institute, Melbourne, Victoria, 8008, Australia
Protein Expr Purif 17:231-8. 1999..These results demonstrate that at least in the model of insect cells, the efficiency of apoA-I synthesis, processing, and secretion depends on apoA-I secondary structure and/or folding...
Characterization of the maturation of human pro-apolipoprotein A-I in an in vitro modelL E Pyle
Baker Medical Research Institute, Melbourne, Victoria, 3008, Australia
Biochemistry 40:3101-8. 2001..Thus, residues within -2 to +4 are involved in forming the cleavage site for the maturation enzyme. The reaction of maturation is inhibited by metalloprotease inhibitors and is dependent upon calcium...
The anti inflammatory effects of high density lipoproteinsA J Murphy
Baker IDI Heart and Diabetes Research Institute, PO Box 6492, St Kilda Road Central, Melbourne, 8008 VIC, Australia
Curr Med Chem 16:667-75. 2009....
The effect of cholesteryl ester transfer protein overexpression and inhibition on reverse cholesterol transportUrbain Tchoua
Baker Heart Research Institute, Melbourne, Victoria, Australia
Cardiovasc Res 77:732-9. 2008..Cholesteryl ester transfer protein (CETP) has a well-established role in lipoprotein metabolism, but the effect of its overexpression or inhibition on the efficiency of reverse cholesterol transport (RCT) is unclear...
High-density lipoprotein reduces the human monocyte inflammatory responseAndrew J Murphy
Laboratories of Vascular Pharmacology, Research Institute, Melbourne, Victoria, Australia
Arterioscler Thromb Vasc Biol 28:2071-7. 2008..Whereas the anti-inflammatory effects of high-density lipoprotein (HDL) on endothelial cells are well described, such effects on monocytes are less studied...
Asymmetry in the lipid affinity of bihelical amphipathic peptides. A structural determinant for the specificity of ABCA1-dependent cholesterol efflux by peptidesAmar A Sethi
Lipoprotein Metabolism Section, Pulmonary and Vascular Medicine Branch, NHLBI, National Institutes of Health, Bethesda, Maryland 20892 1508, USA
J Biol Chem 283:32273-82. 2008..03)). In summary, we describe a novel bihelical peptide with asymmetry in the lipid affinity of its helices and properties similar to apoA-I in terms of specificity for cholesterol efflux by the ABCA1 transporter and low cytotoxicity...
Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaqueJames A Shaw
Department of Cardiovascular Medicine, Alfred Hospital Baker IDI Heart and Diabetes Institute, PO Box 6492, St Kilda Rd Central 8008, Australia
Circ Res 103:1084-91. 2008..These changes may contribute to the cardioprotective effects of HDL...
HIV infection and high-density lipoprotein: the effect of the disease vs the effect of treatmentHonor Rose
Baker Heart Research Institute, Melbourne 3004, Australia
Metabolism 55:90-5. 2006..These data suggest that hypoalphalipoproteinemia in patients with HIV is likely to be secondary to HIV infection itself...
Reconstituted high-density lipoprotein attenuates platelet function in individuals with type 2 diabetes mellitus by promoting cholesterol effluxAnna C Calkin
Diabetes Complications Laboratory, Baker IDI Heart and Diabetes Institute, PO Box 6492, St Kilda Rd Central, Melbourne, Australia 8008
Circulation 120:2095-104. 2009..Reconstituted high-density lipoprotein (rHDL) has short-term beneficial effects on atherosclerotic plaques, but whether it can effectively reduce the reactivity of diabetic platelets is not known...
Genetic factors affecting HDL levels, structure, metabolism and functionDmitri Sviridov
Baker Heart Research Institute, Melbourne, Victoria, Australia
Curr Opin Lipidol 18:157-63. 2007..The present review focuses on various approaches to establish genetic determinants of the HDL concentration, structure and function...
Structure/function relationships of apolipoprotein a-I mimetic peptides: implications for antiatherogenic activities of high-density lipoproteinWilissa D'Souza
Baker Heart and Diabetes Institute, PO Box 6492, St Kilda Rd, Melbourne 8008, Australia
Circ Res 107:217-27. 2010..Apolipoprotein (apoA)-I mimetic peptides are a promising type of anti-atherosclerosis therapy, but how the structural features of these peptides relate to the multiple antiatherogenic functions of HDL is poorly understood...
Structure-function studies of apoA-I variants: site-directed mutagenesis and natural mutationsDmitri Sviridov
Baker Medical Research Institute, P O Box 6492, St Kilda Road Central, Melbourne, Victoria, 8008, Australia
J Lipid Res 43:1283-92. 2002....
Advanced glycation end-products (AGEs) and functionality of reverse cholesterol transport in patients with type 2 diabetes and in mouse modelsH Low
Baker Heart and Diabetes Institute, PO Box 6492, St Kilda Road Central, Melbourne, VIC 8008, Australia
Diabetologia 55:2513-21. 2012..We investigated the contribution of AGEs to the impairment of reverse cholesterol transport (RCT) variables in diabetic individuals and in two animal models of diabetic obesity and of renal impairment...
Antiretroviral compounds and cholesterol efflux from macrophagesNigora Mukhamedova
BakerIDI Heart and Diabetes Institute, Melbourne, Australia
Atherosclerosis 206:439-43. 2009..The objective of this study was to assess the effect of various classes of anti-HIV drugs on cellular cholesterol efflux...
Physical fitness and reverse cholesterol transportBeata Olchawa
Baker Heart Research Institute, Wynn Domain, Melbourne, Victoria, Australia
Arterioscler Thromb Vasc Biol 24:1087-91. 2004..8%+/-0.8% versus 16.2%+/-0.3%; P<0.03). CONCLUSIONS: The likely reason for higher HDL concentration in physically fit people is increased formation of HDL from apoA-I and cellular lipids...
Natural mutations of apolipoprotein A-I impairing activation of lecithin:cholesterol acyltransferaseAnh Hoang
Wynn Domain, Baker Medical Research Institute, PO Box 6492 St Kilda Rd Central, Melbourne VIC 8008, Australia
Biochim Biophys Acta 1631:72-6. 2003....
A mouse model of harlequin ichthyosis delineates a key role for Abca12 in lipid homeostasisIan Smyth
Department of Biochemistry and Molecular Biology, Monash University, Melbourne, Australia
PLoS Genet 4:e1000192. 2008..Furthermore, we identify Abca12 as a mediator of Abca1-regulated cellular cholesterol efflux, a finding that may have significant implications for other diseases of lipid metabolism and homeostasis, including atherosclerosis...
ABCA1 expression in humans is associated with physical activity and alcohol consumptionAnh Hoang
Baker Heart Research Institute, Commercial Road, PO Box 6492, St Kilda Road Central, Melbourne, VIC 8008, Australia
Atherosclerosis 197:197-203. 2008..In conclusion, ABCA1 expression in human leukocytes and muscle is associated with physical activity and alcohol consumption, respectively...
Expression of caveolin-1 enhances cholesterol efflux in hepatic cellsYing Fu
Wynn Domain, Baker Heart Research Institute, Melbourne, Victoria 8008, Australia
J Biol Chem 279:14140-6. 2004..We conclude that overexpression of caveolin-1 in hepatic cells stimulates cholesterol efflux by enhancing transfer of cholesterol to cholesterol-rich domains in the plasma membrane...
Demethylation using the epigenetic modifier, 5-azacytidine, increases the efficiency of transient transfection of macrophagesGenevieve Escher
Baker Heart Research Institute, Melbourne, Victoria, 8008, Australia
J Lipid Res 46:356-65. 2005..However, transfection with CYP27A1 led to a 2- to 4-fold increase of cholesterol efflux. We conclude that treatment with 5-azacytidine can be used for high-efficiency transient transfection of macrophages...
Indices of reverse cholesterol transport in subjects with metabolic syndrome after treatment with rosuvastatinDmitri Sviridov
Baker Heart Research Institute, Melbourne, Australia
Atherosclerosis 197:732-9. 2008..The effects of the statin, rosuvastatin on indices of reverse cholesterol transport were studied in a randomized, placebo-controlled, cross-over trial in 25 overweight subjects with defined metabolic syndrome...
Expression of sterol 27-hydroxylase (CYP27A1) enhances cholesterol effluxGenevieve Escher
Wynn Domain, Baker Medical Research Institute, Melbourne, Victoria 8008, Australia
J Biol Chem 278:11015-9. 2003..Expression of CYP27A1 in CHOP cells did not affect ABCA1 expression and abundance of ABCA1 protein. Thus, introduction of CYP27A1 into cells stimulates cholesterol efflux and therefore may increase protection against atherosclerosis...
Impact of freezing on high-density lipoprotein functionalityJ Rajinda Kekulawala
Baker Heart Research Institute, Melbourne, VIC 8008, Australia
Anal Biochem 379:213-5. 2008..Freezing also resulted in approximately 10% loss of HDL in the samples. We conclude that freezing HDL in the presence of 10% sucrose preserves its structural and functional properties...
HDL-replacement therapy: mechanism of action, types of agents and potential clinical indicationsAlan T Remaley
National Institutes of Health, Lipoprotein Metabolism Section, Pulmonary and Vascular Medicine Branch, National Heart, Lung, and Blood Institute, Bethesda, MD 20892 21508, USA
Expert Rev Cardiovasc Ther 6:1203-15. 2008..Finally, HDL-replacement therapy will be put into perspective by summarizing the current gaps in our knowledge of HDL metabolism and identifying challenges for future research in this area...
HIV and cardiovascular disease: contribution of HIV-infected macrophages to development of atherosclerosisMichael Bukrinsky
PLoS Med 4:e43. 2007
Human immunodeficiency virus impairs reverse cholesterol transport from macrophagesZahedi Mujawar
The George Washington University, Washington, District of Columbia, USA
PLoS Biol 4:e365. 2006....
Dose-dependent regulation of high-density lipoprotein metabolism with rosuvastatin in the metabolic syndromeEsther M M Ooi
Metabolic Research Centre, School of Medicine and Pharmacology, Royal Perth Hospital, University of Western Australia, Perth, Western Australia 6847, Australia
J Clin Endocrinol Metab 93:430-7. 2008..Rosuvastatin has been shown to increase HDL cholesterol concentration, but the mechanisms remain unclear...
Human immunodeficiency virus infection and macrophage cholesterol metabolismMichael Bukrinsky
Department of Microbiology, Immunology and Tropical Medicine, 2300 I St, N W, Ross Hall, Rm 234, Washington, DC 20037, USA
J Leukoc Biol 80:1044-51. 2006..Further elucidation of the mechanisms connecting viral infection and macrophage cholesterol metabolism may be fruitful for developing approaches to treatment of atherosclerosis and viral diseases...
Dose-dependent effect of rosuvastatin on VLDL-apolipoprotein C-III kinetics in the metabolic syndromeEsther M M Ooi
Metabolic Research Centre, School of Medicine and Pharmacology, Royal Perth Hospital, Universityof Western Australia, Perth, Western Australia
Diabetes Care 31:1656-61. 2008..This study investigated the dose-dependent effect of rosuvastatin on VLDL apoC-III transport in men with the metabolic syndrome...
